NCT06745973View on ClinicalTrials.gov

An Exploratory Clinical Study Evaluating EPI-003 Injection for the Treatment of Chronic Hepatitis B

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 20, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Chronic Hepatitis B
Interventions
DRUG

EPI-003

Intravenous (IV) infusion.

Trial Locations (1)

Unknown

Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

Sponsors
All Listed Sponsors
lead

Epigenic Therapeutics, Inc

INDUSTRY

NCT06745973 - An Exploratory Clinical Study Evaluating EPI-003 Injection for the Treatment of Chronic Hepatitis B | Biotech Hunter | Biotech Hunter